Individuals who have inherited a genetic predisposition for high LDL cholesterol may benefit from a simple gene-editing technique, scientists say.
The work was carried out by a team led by Dr Andrew Bellinger of Verve Therapeutics in Boston, USA, and presented at the American Heart Association’s Scientific Sessions 2023 held in Philadelphia.